XPRIZE Healthspan finalists and their trial plans: an article outlining how diverse aging therapies will be judged using shared measures and centralized infrastructure.
Key Takeaways
- Twenty teams advanced to XPRIZE Healthspan final trials testing diverse interventions to improve muscle
- Ten teams received $1 million Milestone 2 awards as finalists prepare clinical testing running from 2026 to 2029
- Centralized data and lab infrastructure will be used to standardize outcome measures across international